Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene for Persistent Hypogonadism in Males with Prolactinomas
NCT00697814Phase 2Completed
- Sponsor
- Federal University of São Paulo
- Start
- Jun 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of clomiphene in hypogonadotropic hypogonadism (HH), sponsored by Federal University of São Paulo. Primary endpoint: Serum Total Testosterone Levels at 12 weeks. Started Jun 2004; status: completed.
02
Drugs
clomiphene
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT00697814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697814.